Universal Health Services, Inc. (UHS) Stock Price & How to Invest

Universal Health Services is a Pennsylvania-based healthcare company that owns and operates acute care hospitals, behavioral health facilities, outpatient centers, and ambulatory surgery locations across the United States and in the United Kingdom. Its two core segments are acute care, which covers general hospitals and emergency and surgical services, and behavioral health, which spans inpatient psychiatric and addiction treatment facilities where UHS is one of the largest operators in the country. The company also expanded its virtual behavioral health reach through the acquisition of Talkspace.

The investment picture centers on scale and steady demand. UHS generated net revenues of roughly $17.4 billion in full-year 2025, up about 9.7 percent year over year, with net income attributable to UHS near $1.49 billion. Growth has continued into 2026, with first-quarter net revenue of about $4.5 billion. Despite that momentum, the stock has often carried a low earnings multiple because investors weigh Medicaid and Medicare reimbursement changes, labor cost pressure, and broader healthcare policy risk against the operating results.

The largest risks are tied to government reimbursement. A meaningful share of UHS revenue comes from Medicare and Medicaid, so changes to those programs, state Medicaid supplemental payment structures, or federal healthcare policy can move earnings materially. Labor costs, including nursing wages and contract labor, remain a swing factor for margins. The behavioral health segment carries regulatory, staffing, and reputational scrutiny given the nature of inpatient psychiatric care. Rising interest expense on debt and integration risk from acquisitions such as Talkspace add further uncertainty. The persistently low earnings multiple suggests the market is pricing these policy and reimbursement risks even as reported results grow.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Universal Health Services, Inc.'s investor relations page or your broker.

• Revenue (FY2025): ~$17.4B
• Net income attributable to UHS (FY2025): ~$1.49B
• Diluted EPS (FY2025): ~$23.10
• Market cap: ~$10B
• P/E ratio: ~7
• Annual dividend / yield: ~$0.80 (~0.5%)

UHS trades at a notably low price-to-earnings multiple, in the high single digits, well below broader market averages and its own longer-run history. That reflects investor caution around reimbursement and policy exposure rather than weak results, since revenue grew about 9.7 percent in 2025 and momentum carried into 2026.

There are three common ways to get UHS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so UHS sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where UHS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

UHS pairs consistent revenue and earnings growth across acute care and behavioral health with a valuation that stays modest because of reimbursement, labor, and policy risk, so the story is a large, profitable operator priced cautiously rather than as a growth name.

Whether UHS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is UHS a buy?, and where the stock could go from here in the UHS stock forecast.

For income investors, whether UHS pays a dividend and how the payout looks is covered in does UHS pay a dividend?